Britain's pharmacies regulator on Tuesday tightened rules for online pharmacies' prescribing obesity drugs, ordering them to ...
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
Discontinuation of GLP-1 receptor agonists in obesity is common, driven by weight regain and socioeconomic factors, impacting treatment effectiveness.
The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...
The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...
Offering expertise on the program are OB-GYN Dr. Donna G. Ivery, Neumours infection expert Chad Neilsen, and Dr. Dacre Knight ...
Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in ...
Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in ...
Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...
American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...